MidDiagnosed 2026-10-02 07:17:42 KSTNNVSAI Stock Diagnostic ReportNovartis inks up to $7.8B deal with Abogen for RNA-encoded therapeuticsNovartis signed a deal worth up to $7.8 billion with Abogen for the development of RNA-encoded therapies, boosting expectations for pipeline expansion.View Source Article ↗ AI CATALYST SCORE65 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤